These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 1684908)

  • 1. Differential growth inhibition of isoquinolinesulfonamides H-8 and H-7 towards multidrug-resistant P388 murine leukaemia cells.
    Ido M; Nagao Y; Higashigawa M; Shibata T; Taniguchi K; Hamazaki M; Sakurai M
    Br J Cancer; 1991 Dec; 64(6):1103-7. PubMed ID: 1684908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of isoquinolinesulphonamide compounds on multidrug-resistant P388 cells.
    Nakamura S; Wakusawa S; Tajima K; Miyamoto K; Hagiwara M; Hidaka H
    J Pharm Pharmacol; 1993 Apr; 45(4):268-73. PubMed ID: 8098366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased phorbol ester receptor and protein kinase C in P388 murine leukemic cells resistant to etoposide.
    Ido M; Sato K; Sakurai M; Inagaki M; Saitoh M; Watanabe M; Hidaka H
    Cancer Res; 1987 Jul; 47(13):3460-3. PubMed ID: 3581082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of multidrug resistance by an immunosuppressive agent FK-506.
    Naito M; Oh-hara T; Yamazaki A; Danki T; Tsuruo T
    Cancer Chemother Pharmacol; 1992; 29(3):195-200. PubMed ID: 1370765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obviation of drug resistance and affinity purification of P-glycoprotein by isoquinolinesulfonamides.
    Hagiwara M; Wakusawa S; Miyamoto K; Hidaka H
    Cancer Lett; 1991 Nov; 60(2):103-7. PubMed ID: 1682033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantrone.
    Kamath N; Grabowski D; Ford J; Kerrigan D; Pommier Y; Ganapathi R
    Biochem Pharmacol; 1992 Sep; 44(5):937-45. PubMed ID: 1356339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circumvention of multidrug resistance in P388 murine leukemia cells by a novel inhibitor of cyclic AMP-dependent protein kinase, H-87.
    Miyamoto K; Wakusawa S; Nakamura S; Koshiura R; Otsuka K; Naito K; Hagiwara M; Hidaka H
    Cancer Lett; 1990 May; 51(1):37-42. PubMed ID: 2337896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosine.
    Wilkoff LJ; Dulmadge DA; Laster WR; Griswold DP
    Cancer Chemother Pharmacol; 1989; 23(3):145-50. PubMed ID: 2924372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal by two dihydropyridine compounds of resistance to multiple anticancer agents in mouse P388 leukemia in vivo and in vitro.
    Kiue A; Sano T; Naito A; Inada H; Suzuki K; Okumura M; Kikuchi J; Sato S; Takano H; Kohno K
    Jpn J Cancer Res; 1990 Oct; 81(10):1057-64. PubMed ID: 1977728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming of vinblastine resistance by isoquinolinesulfonamide compounds in adriamycin-resistant leukemia cells.
    Wakusawa S; Nakamura S; Tajima K; Miyamoto K; Hagiwara M; Hidaka H
    Mol Pharmacol; 1992 Jun; 41(6):1034-8. PubMed ID: 1614407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a membrane-associated protein kinase of multidrug-resistant HL60 cells which phosphorylates P-glycoprotein.
    Staats J; Marquardt D; Center MS
    J Biol Chem; 1990 Mar; 265(7):4084-90. PubMed ID: 1968066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inhibitor of protein kinase C, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine(H-7) inhibits TPA-induced reduction of vincristine uptake from P388 murine leukemic cell.
    Ido M; Asao T; Sakurai M; Inagaki M; Saito M; Hidaka H
    Leuk Res; 1986; 10(9):1063-9. PubMed ID: 3762216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
    Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
    Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased DNA polymerase sensitivity to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in P388 murine leukemic cells resistant to vincristine.
    Higashigawa M; Ido M; Nagao Y; Kuwabara H; Hori H; Ohkubo T; Kawasaki H; Sakurai M
    Leuk Res; 1991; 15(8):675-81. PubMed ID: 1895749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance.
    Loor F; Boesch D; Gavériaux C; Jachez B; Pourtier-Manzanedo A; Emmer G
    Br J Cancer; 1992 Jan; 65(1):11-8. PubMed ID: 1346365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
    Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G
    Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.
    Tsuruo T; Iida H; Yamashiro M; Tsukagoshi S; Sakurai Y
    Biochem Pharmacol; 1982 Oct; 31(19):3138-40. PubMed ID: 7150340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of multidrug resistance by 7-O-benzoylpyripyropene A in multidrug-resistant tumor cells.
    Rho MC; Hayashi M; Fukami A; Obata R; Sunazuka T; Tomoda H; Komiyama K; Omura S
    J Antibiot (Tokyo); 2000 Oct; 53(10):1201-6. PubMed ID: 11132967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance of murine leukemia cells characterization and correlation with cytochrome P-450 dependent activities, cytosolic calcium and cell cycle state.
    Pfeil D; Bergmann J; Fichtner I; Stein U; Hentschel M; Rothe I; Goan SR
    Anticancer Res; 1994; 14(2A):571-6. PubMed ID: 7912495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
    Sato W; Fukazawa N; Nakanishi O; Baba M; Suzuki T; Yano O; Naito M; Tsuruo T
    Cancer Chemother Pharmacol; 1995; 35(4):271-7. PubMed ID: 7828268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.